Co-Diagnostics, Inc. (CODX)
NASDAQ: CODX · Real-Time Price · USD
3.120
-0.250 (-7.42%)
At close: Jun 22, 2026, 4:00 PM EDT
3.200
+0.080 (2.56%)
After-hours: Jun 22, 2026, 7:03 PM EDT
Co-Diagnostics Employees
Co-Diagnostics had 115 employees as of December 31, 2025. The number of employees decreased by 17 or -12.88% compared to the previous year.
Employees
115
Change (1Y)
-17
Growth (1Y)
-12.88%
Revenue / Employee
$6,245
Profits / Employee
-$421,763
Market Cap
11.41M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 115 | -17 | -12.88% |
| Dec 31, 2024 | 132 | -23 | -14.84% |
| Dec 31, 2023 | 155 | 10 | 6.90% |
| Dec 31, 2022 | 145 | 44 | 43.56% |
| Dec 31, 2021 | 101 | 62 | 158.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Trinity Biotech | 287 |
| Vivos Therapeutics | 270 |
| IRIDEX | 93 |
| Lifeward | 81 |
| Picard Medical | 75 |
| IceCure Medical | 69 |
| VolitionRx | 67 |
| Adagio Medical Holdings | 41 |
CODX News
- 11 days ago - Co-Diagnostics signs distribution agreement for CO-Dx PCR Pro in Mexico - TheFly
- 11 days ago - Co-Diagnostics Advances Latin American Commercialization Strategy for Co-Dx™ PCR Pro® with Mexico Distributor Agreement - PRNewsWire
- 20 days ago - Co-Diagnostics announces continued progress in Ebola PCR development program - TheFly
- 20 days ago - Co-Diagnostics trading halted, volatility trading pause - TheFly
- 20 days ago - Co-Diagnostics trading resumes - TheFly
- 20 days ago - Co-Diagnostics and CoSara Advance Ebola PCR Test Development and Co-Dx™ PCR Point-of-Care Platform Capabilities - PRNewsWire
- 25 days ago - Co-Diagnostics files to sell 4.94M shares of common stock for holders - TheFly
- 25 days ago - Co-Diagnostics Registration statement: Registration filing - Filings